Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for APO-RIVASTIGMINE

Brand name

APO-RIVASTIGMINE

Company Name

APOTEX INC

Drug Identification Number

02336758

Ingredients & Strength

RIVASTIGMINE (6 MG)

ATC Code

N06DA

ATC Descriptor

ANTI-DEMENTIA DRUGS

Status

MARKETED

Shortage reports
Brand name	Packaging size	Status	Date Created	Date Updated	Reports
APO-RIVASTIGMINE	100 BTL	Resolved	2017-07-26	2018-03-27	17322
APO-RIVASTIGMINE	100 BTL	Resolved	2019-07-03	2019-10-07	88360
APO-RIVASTIGMINE	100 BTL	Resolved	2021-12-03	2021-12-13	150440
APO-RIVASTIGMINE	100 BTL	Resolved	2024-09-20	2024-10-04	238239
APO-RIVASTIGMINE	100 BTL	Resolved	2025-03-20	2025-07-17	253075

1

Showing 1 to 5 of 5

Discontinuation reports
Brand name	Packaging size	Status	Date Created	Date Updated	Reports

1

Showing 1 to 0 of 0

Reports for APO-RIVASTIGMINE

Brand name APO-RIVASTIGMINE

Brand name

APO-RIVASTIGMINE